IL-22 Protects against Tissue Damage during Cutaneous Leishmaniasis
نویسندگان
چکیده
منابع مشابه
IL-22 Protects against Tissue Damage during Cutaneous Leishmaniasis
Cutaneous leishmaniasis is a disease characterized by ulcerating skin lesions, the resolution of which requires an effective, but regulated, immune response that limits parasite growth without causing permanent tissue damage. While mechanisms that control the parasites have been well studied, the factors regulating immunopathologic responses are less well understood. IL-22, a member of the IL-1...
متن کاملIL-22 vs. IL-22: The Tissue Matters
IL-22 is a cytokine recently discovered to be produced by TH17 cells. Its receptor is expressed in the skin, liver, the digestive and the respiratory tract where IL-22 conveys signals of the immune system directly to the tissue. IL-22 is involved in the host defense against extracellular pathogens as well as in autoimmune inflammatory diseases and exerts, depending on the tissue and inflammator...
متن کاملBerberine Protects Against murine malaria-Induced Spleen Tissue Damage
Malaria is one of the most severe public health problems worldwide. Here, we investigated the ameliorative role of berberine against Plasmodium chabaudi-induced spleen injury. Mice were divided into 3 groups. The first group served as a vehicle control, the second group was infected with 10 P. chabaudi infected erythrocytes and the third group was infected with P. chabaudi then treated with 10 ...
متن کاملImmunization with alpha-toxin toxoid protects the cornea against tissue damage during experimental Staphylococcus aureus keratitis.
Alpha-toxin is a major virulence factor in Staphylococcus aureus keratitis. Active or passive immunization with alpha-toxin toxoid could protect against corneal damage. Results show that either form of immunization did not kill bacteria but did significantly protect against corneal pathology, especially epithelial erosion.
متن کاملProtective Immunity and Vaccination Against Cutaneous Leishmaniasis
Although a great deal of knowledge has been gained from studies on the immunobiology of leishmaniasis, there is still no universally acceptable, safe, and effective vaccine against the disease. This strongly suggests that we still do not completely understand the factors that control and/or regulate the development and sustenance of anti-Leishmania immunity, particularly those associated with s...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: PLOS ONE
سال: 2015
ISSN: 1932-6203
DOI: 10.1371/journal.pone.0134698